| International staging system for multiple myeloma PR Greipp, JS Miguel, BGM Durie, JJ Crowley, B Barlogie, J Bladé, ... Journal of clinical oncology 23 (15), 3412-3420, 2005 | 3700 | 2005 |
| International uniform response criteria for multiple myeloma BGM Durie, JL Harousseau, JS Miguel, J Blade, B Barlogie, K Anderson, ... Leukemia 20 (9), 1467-1473, 2006 | 3441 | 2006 |
| International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma S Kumar, B Paiva, KC Anderson, B Durie, O Landgren, P Moreau, ... The lancet oncology 17 (8), e328-e346, 2016 | 2476 | 2016 |
| Fluorouracil leucovorin and oxaliplatin with and without cetuximab in the first-line treatment of metastatic colorectal cancer C Bokemeyer, I Bondarenko, A Makhson, JT Hartmann, J Aparicio, ... Journal of clinical oncology 27 (5), 663-671, 2009 | 2171 | 2009 |
| Carfilzomib, lenalidomide, and dexamethasone for relapsed multiple myeloma AK Stewart, SV Rajkumar, MA Dimopoulos, T Masszi, I Špička, A Oriol, ... New England Journal of Medicine 372 (2), 142-152, 2015 | 1581 | 2015 |
| The European Cancer Anaemia Survey (ECAS): a large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients H Ludwig, S Van Belle, P Barrett-Lee, G Birgegård, C Bokemeyer, ... European journal of cancer 40 (15), 2293-2306, 2004 | 1356 | 2004 |
| Consensus recommendations for the uniform reporting of clinical trials: report of the International Myeloma Workshop Consensus Panel 1 SV Rajkumar, JL Harousseau, B Durie, KC Anderson, M Dimopoulos, ... Blood, The Journal of the American Society of Hematology 117 (18), 4691-4695, 2011 | 1124 | 2011 |
| International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders A Dispenzieri, R Kyle, G Merlini, JS Miguel, H Ludwig, R Hájek, ... Leukemia 23 (2), 215-224, 2009 | 1049 | 2009 |
| Prevention of thalidomide-and lenalidomide-associated thrombosis in myeloma A Palumbo, SV Rajkumar, MA Dimopoulos, PG Richardson, J San Miguel, ... Leukemia 22 (2), 414-423, 2008 | 1022 | 2008 |
| Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and … RA Kyle, BGM Durie, SV Rajkumar, O Landgren, J Bladé, G Merlini, ... Leukemia 24 (6), 1121-1127, 2010 | 1016 | 2010 |
| Carfilzomib and dexamethasone versus bortezomib and dexamethasone for patients with relapsed or refractory multiple myeloma (ENDEAVOR): a randomised, phase 3, open-label … MA Dimopoulos, P Moreau, A Palumbo, D Joshua, L Pour, R Hájek, ... The Lancet Oncology 17 (1), 27-38, 2016 | 988 | 2016 |
| Lenalidomide and dexamethasone in transplant-ineligible patients with myeloma L Benboubker, MA Dimopoulos, A Dispenzieri, J Catalano, AR Belch, ... New England Journal of Medicine 371 (10), 906-917, 2014 | 908 | 2014 |
| Multiple myeloma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up P Moreau, J San Miguel, P Sonneveld, MV Mateos, E Zamagni, ... Annals of oncology 28, iv52-iv61, 2017 | 843 | 2017 |
| Geriatric assessment predicts survival and toxicities in elderly myeloma patients: an International Myeloma Working Group report A Palumbo, S Bringhen, MV Mateos, A Larocca, T Facon, SK Kumar, ... Blood, The Journal of the American Society of Hematology 125 (13), 2068-2074, 2015 | 766 | 2015 |
| Myeloma management guidelines: a consensus report from the Scientific Advisors of the International Myeloma Foundation BGM Durie, RA Kyle, A Belch, W Bensinger, J Blade, M Boccadoro, ... The Hematology Journal 4 (6), 379-398, 2003 | 619 | 2003 |
| Erythropoietin treatment of anemia associated with multiple myeloma H Ludwig, E Fritz, H Kotzmann, P Höcker, H Gisslinger, U Barnas New England Journal of Medicine 322 (24), 1693-1699, 1990 | 618 | 1990 |
| The prognostic significance of proliferating cell nuclear antigen, epidermal growth factor receptor, and mdr gene expression in colorectal cancer A Mayer, M Takimoto, E Fritz, G Schellander, K Kofler, H Ludwig Cancer 71 (8), 2454-2460, 1993 | 556 | 1993 |
| Consensus recommendations for standard investigative workup: report of the International Myeloma Workshop Consensus Panel 3 M Dimopoulos, R Kyle, JP Fermand, SV Rajkumar, J San Miguel, ... Blood, The Journal of the American Society of Hematology 117 (18), 4701-4705, 2011 | 533 | 2011 |
| Renal impairment in patients with multiple myeloma: a consensus statement on behalf of the International Myeloma Working Group MA Dimopoulos, E Terpos, A Chanan-Khan, N Leung, H Ludwig, ... Journal of clinical oncology 28 (33), 4976-4984, 2010 | 533 | 2010 |
| MDR1 gene expression and treatment outcome in acute myeloid leukemia R Pirker, J Wallner, K Geissler, W Linkesch, OA Haas, P Bettelheim, ... JNCI: Journal of the National Cancer Institute 83 (10), 708-712, 1991 | 474 | 1991 |
